Literature DB >> 6175811

Pharmacokinetics of amiodarone in rats.

E Riva, M Gerna, P Neyroz, R Urso, I Bartosek, A Guaitani.   

Abstract

We studied the kinetics of amiodarone in the rat. After an intravenous dose of 50 mg/kg, the time-course of the drug concentrations was assessed by high-pressure liquid chromatography in blood and tissues up to 16 h. The drug disappeared from the blood with an elimination half-life (t1/2beta) of 514 min and distributed extensively into tissues [apparent volume of distribution (Vd)= 29.51 L/kg]. Concentrations were highest in liver, kidney, and heart, and lowest at all times in the brain. The highest concentrations were found within 5-30 min of administration. Amiodarone accumulated extensively in adipose tissue and reached a fat/blood concentration ratio of about 1,000 at 16 h. Single-pass rat liver perfusion experiments gave an hepatic extraction ratio of 0.49 and an intrinsic clearance of 5.48 ml/min. Amiodarone disappearance in rat liver recirculation experiments was biexponential, with a half-life of 58 min.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175811     DOI: 10.1097/00005344-198203000-00016

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  17 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs. Rationale and current status.

Authors:  R Latini; A P Maggioni; A Cavalli
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Bioavailability of drugs with long elimination half-lives.

Authors:  R Urso; L Aarons
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion.

Authors:  G C Storey; P C Adams; R W Campbell; D W Holt
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

Review 4.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

5.  A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.

Authors:  Jing-Tao Lu; Ying Cai; Feng Chen; Wei-Wei Jia; Zhe-Yi Hu; Yuan-Sheng Zhao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

6.  Anticonvulsant and hypnotic effects of amiodarone.

Authors:  Gunnur Ozbakis-Dengiz; Aysegul Bakirci
Journal:  J Zhejiang Univ Sci B       Date:  2009-04       Impact factor: 3.066

7.  Amiodarone pharmacokinetics. I. Acute dose-dependent disposition studies in rats.

Authors:  S J Weir; C T Ueda
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

8.  Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.

Authors:  W J Martin; D M Howard
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

9.  Amiodarone kinetics after single i.v. bolus and multiple dosing in healthy volunteers.

Authors:  E Riva; L Aarons; R Latini; P Neyroz; R Urso
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer.

Authors:  S E Bates; B Meadows; B R Goldspiel; A Denicoff; T B Le; E Tucker; S M Steinberg; L J Elwood
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.